133 related articles for article (PubMed ID: 37109589)
1. Correlation between Maspin Levels in Different Biological Samples and Pathologic Features in Colorectal Adenocarcinomas.
Bratei AA; Stefan-van Staden RI
Life (Basel); 2023 Apr; 13(4):. PubMed ID: 37109589
[TBL] [Abstract][Full Text] [Related]
2. Minimally Invasive and Fast Diagnosis of Gastric Cancer Based on Maspin Levels in Different Biological Samples.
Bratei AA; Stefan-van Staden RI
Diagnostics (Basel); 2023 May; 13(11):. PubMed ID: 37296710
[TBL] [Abstract][Full Text] [Related]
3. Correlations between MSH2 and MSH6 Concentrations in Different Biological Fluids and Clinicopathological Features in Colorectal Adenocarcinoma Patients and Their Contribution to Fast and Early Diagnosis of Colorectal Adenocarcinoma.
Bratei AA; Stefan-van Staden RI
Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137434
[TBL] [Abstract][Full Text] [Related]
4. Nuclear maspin expression: A biomarker for budding assessment in colorectal cancer specimens.
Banias L; Gurzu S; Kovacs Z; Bara T; Bara T; Jung I
Pathol Res Pract; 2017 Sep; 213(9):1227-1230. PubMed ID: 28780084
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical-based molecular subtyping of colorectal carcinoma using maspin and markers of epithelial-mesenchymal transition.
Banias L; Jung I; Bara T; Fulop Z; Simu P; Simu I; Satala C; Gurzu S
Oncol Lett; 2020 Feb; 19(2):1487-1495. PubMed ID: 31966075
[TBL] [Abstract][Full Text] [Related]
6. Expression of maspin in colorectal cancer.
Umekita Y; Souda M; Yoshida H
In Vivo; 2006; 20(6B):797-800. PubMed ID: 17203770
[TBL] [Abstract][Full Text] [Related]
7. Nuclear maspin expression correlates with the CpG island methylator phenotype and tumor aggressiveness in colorectal cancer.
Kim JH; Cho NY; Bae JM; Kim KJ; Rhee YY; Lee HS; Kang GH
Int J Clin Exp Pathol; 2015; 8(2):1920-8. PubMed ID: 25973084
[TBL] [Abstract][Full Text] [Related]
8. Stochastic microsensors based on modified graphene for pattern recognition of maspin in biological samples.
Stefan-van Staden RI; Bogea IM; Ilie-Mihai RM; Gheorghe DC; Coroş M; Pruneanu SM
Anal Bioanal Chem; 2022 May; 414(12):3667-3673. PubMed ID: 35266021
[TBL] [Abstract][Full Text] [Related]
9. Shift from cytoplasmic to nuclear maspin expression correlates with shorter overall survival in node-negative colorectal cancer.
Märkl B; Arnholdt HM; Jähnig H; Schenkirsch G; Herrmann RA; Haude K; Spatz H; Anthuber M; Schlimok G; Oruzio D
Hum Pathol; 2010 Jul; 41(7):1024-33. PubMed ID: 20334895
[TBL] [Abstract][Full Text] [Related]
10. Loss of maspin is a helpful prognosticator in colorectal cancer: a tissue microarray analysis.
Boltze C
Pathol Res Pract; 2005; 200(11-12):783-90. PubMed ID: 15792121
[TBL] [Abstract][Full Text] [Related]
11. Expression of maspin in colon cancers: its relationship with p53 expression and microvessel density.
Song SY; Lee SK; Kim DH; Son HJ; Kim HJ; Lim YJ; Lee WY; Chun HK; Rhee JC
Dig Dis Sci; 2002 Aug; 47(8):1831-5. PubMed ID: 12184537
[TBL] [Abstract][Full Text] [Related]
12. Maspin is a marker for early recurrence in primary stage III and IV colorectal cancer.
Snoeren N; Emmink BL; Koerkamp MJ; van Hooff SR; Goos JA; van Houdt WJ; de Wit M; Prins AM; Piersma SR; Pham TV; Belt EJ; Bril H; Stockmann HB; Meijer GA; van Hillegersberg R; Holstege FC; Jimenez CR; Fijneman RJ; Kranenburg OW; Rinkes IH
Br J Cancer; 2013 Sep; 109(6):1636-47. PubMed ID: 24002600
[TBL] [Abstract][Full Text] [Related]
13. Maspin as a Prognostic Marker for Early Stage Colorectal Cancer With Microsatellite Instability.
Tanaka A; Wang JY; Shia J; Zhou Y; Ogawa M; Hendrickson RC; Klimstra DS; Roehrl MHA
Front Oncol; 2020; 10():945. PubMed ID: 32587829
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance of Subcellular Localization of Maspin in Patients with Pathological Stage IA Lung Adenocarcinoma.
Ohno T; Kubouchi Y; Wakahara M; Nosaka K; Sakabe T; Haruki T; Miwa K; Taniguchi Y; Nakamura H; Umekita Y
Anticancer Res; 2018 May; 38(5):3001-3007. PubMed ID: 29715131
[TBL] [Abstract][Full Text] [Related]
15. Interaction of arylsulfatases A and B with maspin: A possible explanation for dysregulation of tumor cell metabolism and invasive potential of colorectal cancer.
Kovacs Z; Jung I; Szalman K; Banias L; Bara TJ; Gurzu S
World J Clin Cases; 2019 Dec; 7(23):3990-4003. PubMed ID: 31832401
[TBL] [Abstract][Full Text] [Related]
16. Expression of p63, TTF-1 and Maspin in Non-Small Cell Lung Carcinoma and Their Effect on the Prognosis and Differential Diagnosis.
Yaman B; Nart D; Ekren PK; Çok G; Veral A
Turk Patoloji Derg; 2015; 31(3):163-74. PubMed ID: 26456962
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases.
Cao D; Zhang Q; Wu LS; Salaria SN; Winter JW; Hruban RH; Goggins MS; Abbruzzese JL; Maitra A; Ho L
Mod Pathol; 2007 May; 20(5):570-8. PubMed ID: 17396143
[TBL] [Abstract][Full Text] [Related]
18. Expression of maspin is associated with the intestinal type of gastric adenocarcinoma.
Kim SM; Cho SJ; Jang WY; Kim DH; Shin HS; Jang MK; Kim HY; Nam ES
Cancer Res Treat; 2005 Aug; 37(4):228-32. PubMed ID: 19956519
[TBL] [Abstract][Full Text] [Related]
19. Nuclear, compared with combined nuclear and cytoplasmic expression of maspin, is linked in lung adenocarcinoma to reduced VEGF-A levels and in Stage I, improved survival.
Frey A; Soubani AO; Adam AK; Sheng S; Pass HI; Lonardo F
Histopathology; 2009 Apr; 54(5):590-7. PubMed ID: 19309490
[TBL] [Abstract][Full Text] [Related]
20. Maspin expression, subcellular localization and clinicopathological correlation in endometrial hyperplasia and endometrial adenocarcinoma.
Blandamura S; Alessandrini L; Saccardi C; Giacomelli L; Fabris A; Borghero A; Litta P
Histol Histopathol; 2014 Jun; 29(6):777-83. PubMed ID: 24346847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
